Stockreport

EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations [Yahoo! Finance]

Adial Pharmaceuticals, Inc  (ADIL) 
US:NASDAQ Investor Relations: adialpharma.com
PDF the company's intellectual property coverage for its lead investigational new drug product, AD04, used for the treatment of alcohol use disorder (AUD). (Source: Adial Ph [Read more]